Metformin × all-cause mortality

SynthesisBritish journal of clinical pharmacology2022

Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.

Adithan Ganesh et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

Went with fewer deaths

−39%−47% to −29%

Bigger than 9 in 10 for all-cause mortality

As reported

OR 0.61, 95% CI 0.53–0.71 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

patients with DM in both unadjusted (OR 0.61 [95% confidence interval:

← favours treatmentfavours comparator →
could be chance
All-cause mortality
OR 0.610.53–0.71
MetforminAll-cause mortality
1 / 3

29 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35122284